Cary Street Partners Financial »

Candel Therapeutics shares owned by Cary Street Partners Financial

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Cary Street Partners Financial from 13F filings

Historical chart of Cary Street Partners Financial investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Cary Street Partners Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Cary Street Partners Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $444k 43k 10.30

More positions owned by Cary Street Partners Financial

Vanguard Value Etf Etf (VTV)
Apple Stock (AAPL)
Vanguard Growth Etf Etf (VUG)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Microsoft Corp Stock (MSFT)
Fairlead Tactical Sector ETF Etf (TACK)
Ishares Msci Eafe Growth Etf Etf (EFG)
Tcw Flexible Income Etf Etf (FLXR)
Ishares Msci Eafe Value Etf Etf (EFV)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Income Etf Etf (JPIE)
Amazon Stock (AMZN)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Nvidia Corporation Stock (NVDA)

View all positions for Cary Street Partners Financial

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International
Sands Capital Ventures

View all funds holding Candel Therapeutics